Anvisa inspection reveals corrosion in equipment and contamination in 80 Ypê batches

A health inspection carried out by Agência Nacional of Vigilância Sanitária (Anvisa) and Centro of Vigilância Sanitária (CVS) of São Paulo at the Ypê factory, in Amparo, in the interior of São Paulo, identified a set of serious irregularities that compromise the safety of cleaning products manufactured on site. Problems include corrosive equipment, critical quality control flaws and the presence of pathogenic bacteria in dozens of batches that remained in storage without formal approval.
The inspection report, concluded at the end of April, characterized the situation as a “high health risk” and recommended the immediate adoption of corrective measures. Anvisa suspended the manufacture and sale of specific batches with final number 1, affecting dishwasher, liquid laundry detergent and disinfectant products. The decision was published last Thursday (7), but the company filed an administrative appeal that automatically suspended the effects of the measure until analysis by the collegiate board, scheduled for this Wednesday (13).
Falhas critical identified in the factory
The inspection document details relevant non-compliances in stages considered critical in the production process. Inspectors found flaws in quality assurance systems, production and quality control itself, which violates good manufacturing practices established by health regulations. Essas deficiencies compromise the integrity of the products and represent a concrete risk of microbiological contamination.
The images attached to the report document equipment used in the manufacturing process of detergents and liquid products showing visible signs of corrosion. The tank for handling dishwashing products was also photographed, revealing an inadequate state of conservation for handling substances that come into contact with kitchen utensils and surfaces used in food preparation.
Além In addition, inspectors discovered remains of products stored and later returned to the filling lines. Essa practice violates quality protocols, as materials that leave the production chain cannot be reintroduced without complete contamination analysis. The presence of returned items on lines increases the risk of spreading unwanted microorganisms to entire batches.
Contaminação microbiological in 80 batches
Entre December 2025 and April 2026, the company recorded results outside the microbiological specification in 80 batches of finished products. The tests identified the presence of Pseudomonas aeruginosa, a pathogenic bacteria capable of causing infections in humans. The report states that none of these batches were formally rejected by internal quality control and remained in storage awaiting “financial definition”.
Essa absence of formal disapproval represents a serious failure in the quality assurance system. The contaminated batches were not immediately segregated or destroyed, remaining in the factory’s inventory in indefinite storage condition. According to Anvisa, cleaning products contaminated with pathogenic bacteria can cause skin and eye infections and respiratory problems, especially in vulnerable people such as the elderly and immunosuppressed individuals.
The identification of 80 contaminated batches in just five months indicates a systematic failure in the manufacturing process. The high number suggests that corrosion problems, inadequate maintenance and control failures affect multiple production cycles, not limited to an isolated incident.
Risco raised toilet and recommendations
The inspection report concluded that all the irregularities observed constitute “a critical situation, characterized as a high health risk”. The regulatory agency demanded the immediate adoption of corrective and preventive measures by the company, warning that non-compliance will result in “compromising the health of consumers and worsening applicable health sanctions”.
The risk of contamination was only identified in batches with final number 1, according to Ypê’s internal production coding. Ainda therefore, the extent of the irregularities found suggests that other lots may be compromised. Anvisa advised consumers who have products from these specific batches at home to immediately suspend use and contact the company’s customer service for recall information.
Microbiological contamination in cleaning products represents a silent threat to public health. Diferentemente of contamination in food, where the risk is immediate, hygiene products can cause progressive damage through repeated contact with inflamed skin, irritated eyes or via inhalation of contaminated vapors during domestic use. The presence of Pseudomonas aeruginosa worsens this situation, as this bacterium is opportunistic and highly virulent in individuals with compromised immune systems.
Cronologia of the case and company position
The suspension of manufacturing and sales was made official by Anvisa last Thursday (May 7). The following Friday, Ypê filed an administrative appeal against the decision. According to the agency’s procedural rules, the appeal automatically suspended the effects of the measure until the collegiate board analyzes the case again. Essa analysis was scheduled for this Wednesday (May 13), when it will be determined whether the suspension remains or is revoked.
In a note sent to the Fantástico program, Ypê stated that the inspection “found no contamination” in its products. The company maintains that it has internal controls to identify and discard items outside the quality standards established by the company. However, this position contrasts with the official Anvisa report, which specifically documents the presence of Pseudomonas aeruginosa in 80 batches and the absence of formal disapproval of these items by internal quality control.
The manufacturer also stated that the areas shown in the inspection images do not have direct contact with the products and are part of a “robust improvement plan” aligned with Anvisa since the previous year. The company reported that production at the Amparo unit has been halted since Thursday to accelerate the adjustments required by the regulatory agency.
Próximos steps in regulatory analysis
The Anvisa collegiate board will analyze the case next Wednesday (13). Essa analysis will take into account the detailed technical report, the administrative appeal presented by Ypê and any additional documentation that the company has submitted demonstrating adjustments already made. The outcome of this meeting will define whether the suspension of manufacturing and marketing remains in force or is revoked.
Consumidores who have products from batches identified as at risk at home must check whether the final number on the package is 1. If confirmed, it is recommended to suspend use immediately and contact Ypê customer service for guidance on recall and replacement. The agency also requests that any adverse health effects related to the use of these products be reported to local health agencies or Anvisa.






